Also known as: Saxenda
Liraglutide is a synthetic peptide and a GLP-1 receptor agonist primarily used in the management of metabolic conditions, particularly obesity and type 2 diabetes. It mimics the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which plays a crucial role in glucose metabolism and appetite regulation. As a member of the fat loss and metabolic peptides category, Liraglutide has gained attention for its potential to aid in weight management and improve metabolic health.
Liraglutide functions by binding to GLP-1 receptors in the pancreas, stimulating insulin secretion in response to elevated blood glucose levels. This action not only helps lower blood sugar but also promotes satiety, leading to reduced food intake.
Additionally, Liraglutide slows gastric emptying, which further contributes to a feeling of fullness after meals. By enhancing insulin sensitivity and regulating appetite, it plays a significant role in metabolic processes.
Liraglutide is a potent GLP-1 receptor agonist that plays a vital role in metabolic health, particularly in weight management and diabetes control. Its multifaceted effects on appetite regulation and insulin sensitivity make it a significant peptide in the field of metabolic research.
Last updated: Feb 25, 2026